|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20,400 KRW | -3.32% |
|
-1.92% | -20.62% |
Kolon Life Science Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was KRW 24.92 million compared to KRW 50.44 million a year ago. Net loss was KRW 4,543.3 million compared to KRW 4,660.01 million a year ago.
Basic loss per share from continuing operations was KRW 398 compared to KRW 650 a year ago. Basic loss per share was KRW 398 compared to KRW 408 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.62% | 17Cr | |
| +56.20% | 82TCr | |
| +39.64% | 63TCr | |
| -7.50% | 35TCr | |
| +15.92% | 32TCr | |
| +6.94% | 29TCr | |
| +13.40% | 24TCr | |
| +0.82% | 22TCr | |
| +13.34% | 22TCr | |
| +8.07% | 17TCr |
KOLON LIFE SCIENCE INC. 
